Boston Scientific · 5 hours ago
EP Mapping Field Intern - Rochester, NY
Rochester, NY
Internship
Hybrid
Intern
$26/hr - $26/hrBoston Scientific is a leader in medical science dedicated to solving critical health challenges. They are seeking an Electrophysiology Mapping Field Intern to join their Cardiology team, where the intern will gain expertise in medical technologies and participate in field sales activities to support the launch of innovative products in the Electrophysiology market.
Health CareMedicalMedical Device
No H1B
Responsibilities
Advance our mission of transforming lives through innovative medical solutions that improve the health of patients around the world
Participate in hospital visits, and field training workshops alongside the Cardiology Field Sales team
Maintain accurate records of sales expenses, customer files and field sales reports required
Conduct all sales activities according to Travel & Entertainment (T&E) guidelines, Industry and Integrity Policies
Will be required to maintain advanced clinical knowledge of cardiac ablation, cardiac ablation components, technical knowledge of EP technology, advancements, and business landscape
Qualification
Required
Current Bachelor's student in your Junior or Senior year or grad student
Pursuing degree in Mechanical Engineering, Biomedical Engineering, Chemical Engineering, Electrical Engineering, or related STEM field
Must have authorization to work in the United States without restriction
Ability to communicate effectively with diverse, cross-functional teams
Self-starter with the ability to identify improvement opportunities and a passion for learning new technologies and finding solutions
Proficient with Microsoft Office tools including Word, Excel, PowerPoint, and Outlook
Ability to travel regionally as needed
Benefits
Variable compensation governed by the Sales Incentive Compensation Plan
Core and optional benefits offered at BSC
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Founded in 1979
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Leadership Team
Michael Mahoney
Chairman, President & CEO
Daniel J. Brennan
Chief Financial Officer
Recent News
2026-01-24
2026-01-23
Company data provided by crunchbase